国泰中证生物医药ETF(512290)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
8,179,918.85 |
结算备付金 |
1,829,324.41 |
1,210,528.69 |
1,981,230.44 |
2,231,428.65 |
存出保证金 |
344,666.51 |
349,834.27 |
406,485.43 |
1,215,910.60 |
交易性金融资产 |
4,026,425,046.97 |
3,584,962,308.59 |
4,661,060,297.43 |
5,558,104,704.16 |
其中:股票投资 |
4,026,425,046.97 |
3,584,962,308.59 |
4,661,060,297.43 |
5,558,104,704.16 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
1,795,706.42 |
310,940.01 |
2,170,206.69 |
8,996,296.04 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
23,667.79 |
- |
298,188.42 |
应收申购款 |
- |
- |
- |
- |
其他资产 |
- |
41,569.21 |
109,080.59 |
159,919.78 |
资产总计 |
4,040,946,469.57 |
3,609,343,953.17 |
4,680,981,860.94 |
5,579,186,366.50 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
- |
77,936.45 |
- |
4,908,513.72 |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
1,762,946.83 |
1,525,872.86 |
2,016,375.40 |
2,271,963.96 |
应付托管费 |
352,589.38 |
305,174.57 |
403,275.08 |
454,392.77 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
4,922.90 |
10,000.16 |
18,765.94 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
3,871,238.96 |
1,671,453.92 |
4,666,156.09 |
2,960,986.21 |
负债合计 |
5,986,775.17 |
3,585,360.70 |
7,095,806.73 |
10,614,622.60 |
所有者权益 |
实收基金 |
4,436,820,694.00 |
4,235,820,694.00 |
4,091,820,694.00 |
5,036,820,694.00 |
未分配利润 |
-401,860,999.60 |
-630,062,101.53 |
582,065,360.21 |
531,751,049.90 |
所有者权益合计 |
4,034,959,694.40 |
3,605,758,592.47 |
4,673,886,054.21 |
5,568,571,743.90 |
负债及所有者权益总计 |
4,040,946,469.57 |
3,609,343,953.17 |
4,680,981,860.94 |
5,579,186,366.50 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年